Elizabeth Ofili, MD, is a Professor of Medicine (Cardiology) and Senior Associate Dean for Clinical and Translational Research at Morehouse School of Medicine, Atlanta, Georgia. In this role, Dr. Ofili directs major NIH research awards, totaling over $150 million, supporting discovery science and training across the translational research spectrum from bench to bedside and community, including the Atlanta Clinical and Translational Science Institute and the RCMI Translational Research Network. She is Founder and Chief Scientific Officer of AccuHealth Technologies, with patented technologies that are “Democratizing Discovery Science and Health with N=Me”
As Multi-PI of the Atlanta Clinical and Translational Science Institute (ACTSI), a citywide collaborative at Emory University, Morehouse School of Medicine and Georgia Institute of Technology, along with partnering health systems and statewide research organizations, Dr. Ofili leads innovative collaborations to advance health equity. Since 2007, ACTSI has engaged over 673 investigators and 134 postdoctoral and pre-doctoral trainees in discovery science, training and community engagement.
Dr. Ofili is the principal investigator of the NIH funded national collaborative for translational research, the RCMI Translational Research Network (RTRN). RTRN includes 18 historically Black, Hispanic, and Minority Serving Institutions across the continental United States, Hawaii and Puerto Rico, competitively funded by NIH to lead research innovations that impact health disparities, and playing a major role in diversifying the biomedical research workforce: Between 2000 and 2015, RCMI institutions have graduated over 3600 PhDs, over 9400 MDs, over 6200 PharmDs, over 2100 Dentists and over 1500 Veterinarians. During the same period, the institutions received $805 million NIH funding, and leveraged those funds to receive additional $3.7 billion in NIH awards, including 1674 prestigious RO1 awards and 14,672 publications.
As multi PI of the National Research Mentoring Network (NRMN) and Director of the Research Resources and Outreach Core, Dr. Ofili engages NIH funded research consortia and academic institutions, to recruit and retain diverse scholars and mentor teams for participation in NRMN.
Dr. Ofili is a recipient of over 50 scientific, services and health policy awards, including induction in the National Academy of Medicine, considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. She is an elected member of the Association of University Cardiologists. She Chairs the Scientific Advisory Board (SAB) of the NASA Translational Research Institute, advising on strategic direction and tactical implementation regarding new emerging technologies. She also serves on the boards of: Georgia BIO, Georgia’s Life Sciences Partner and Alliant Health Solutions, a Quality Improvement Organization contracting with the Centers for Medicare and Medicaid Services to provide quality care to patients with End Stage Renal Disease and other chronic conditions. Dr. Ofili has published over 150 scientific papers and book chapters. Dr Ofili is Founder and Chief Scientific Officer of the Chief Gregory and Chief Mrs Felicia Ofili Foundation (CGFO) whose mission is to support Girls STEAM Education (Science, Technology, Engineering, Arts & Culture, Mathematics) through Experiential Learning, Teacher Professional Development, and Environmental Health, in underserved rural towns across sub Saharan Africa.
Dr. Ofili graduated with distinction from the Ahmadu Bello University, Zaria, Nigeria, completed internal medicine residency at Oral Roberts University, Tulsa Oklahoma, cardiology fellowship at Washington University in St Louis, Missouri, and Advanced Echocardiography research fellowship at St Louis University, St Louis, Missouri. She completed the Master of Public Health at Johns Hopkins University, Baltimore, Maryland.